BSE · AUROLAB

Auro Laboratories Ltd.

Sector: Healthcare · ISIN: INE292C01011

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#2,599

of 5,004 stocks

🏆 New peak

▲ 181W

Peak #2,599 · 01 Oct 2026

Operating in Healthcare, Auro Laboratories Ltd. is growing revenue rapidly, commands a premium earnings multiple, and posts a modest return on equity. Ownership as of Jun 2026.

Market Cap

152.70 Cr

P/E Ratio

43.21

P/B Ratio

3.29

ROE

7.62%

ROCE

9.95%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	8.77 Cr	9.83 Cr	9.39 Cr	8.84 Cr
Net Profit	1.05 Cr	97.06 L	1.95 Cr	71.57 L
EPS	1.68	1.56	3.13	1.15
Operating Profit	2.50 Cr	3.09 Cr	3.26 Cr	2.68 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

52.40%

Public

47.60%

PUBLIC BREAKDOWN

DII

0.01%

MF (within DII)

0.01%

Individuals

42.73%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs